Poly[(ethylene oxide)-co-(methylene ethylene oxide)]: A hydrolytically-degradable poly(ethylene oxide) platform

Area of Science:

• Polymer Chemistry
• Biomaterials Science
• Drug Delivery

Background:

• Poly(ethylene oxide) (PEO) is widely used in biomedical applications due to its biocompatibility and stealth properties.
• Current PEGylation strategies lack inherent degradability, limiting long-term applications and necessitating secondary removal procedures.

Purpose of the Study:

• To develop a facile method for introducing hydrolytic degradability into poly(ethylene oxide) (PEO).
• To create a PEO-based material compatible with existing PEGylation strategies.
• To investigate the degradation mechanism and pH-sensitivity of the modified PEO.

Main Methods:

• Copolymerization of ethylene oxide with methylene ethylene oxide (MEO) units to form poly[(ethylene oxide)-co-(methylene ethylene oxide)].
• Characterization of polymer structure and degradation byproducts.
• Assessment of hydrolytic degradation rates at different pH values (pH 5 and 7.4) and temperatures (37 °C and 6 °C) in PBS buffer.

Main Results:

• Successful incorporation of MEO units into the PEO backbone achieved tunable hydrolytic degradability.
• Degradation byproducts were consistent with an acid-catalyzed vinyl-ether hydrolysis mechanism.
• The degradation rate was pH-sensitive, significantly faster at pH 5 compared to pH 7.4 at 37 °C.
• Long-term stability was observed in solid-state or at pH 7.4 and 6 °C.

Conclusions:

• The developed poly[(ethylene oxide)-co-(methylene ethylene oxide)] copolymers offer a promising platform for creating degradable PEO-based materials.
• The pH-sensitive degradation allows for controlled release applications and tunable material lifetimes.
• This approach is compatible with current PEGylation strategies, broadening its potential in drug delivery and medical devices.